{"organizations": [], "uuid": "f3f108a205606add3bdd4ad2c86006a93c173bb3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/10/business-wire-perkinelmer-appoints-james-mock-as-chief-financial-officer.html", "country": "US", "domain_rank": 767, "title": "PerkinElmer Appoints James Mock as Chief Financial Officer", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-11T00:30:00.000+03:00", "replies_count": 0, "uuid": "f3f108a205606add3bdd4ad2c86006a93c173bb3"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/10/business-wire-perkinelmer-appoints-james-mock-as-chief-financial-officer.html", "ord_in_thread": 0, "title": "PerkinElmer Appoints James Mock as Chief Financial Officer", "locations": [], "entities": {"persons": [{"name": "james mock", "sentiment": "negative"}, {"name": "robert f. friel", "sentiment": "none"}, {"name": "andy wilson", "sentiment": "none"}, {"name": "jamey", "sentiment": "none"}, {"name": "james m. mock", "sentiment": "none"}, {"name": "mock", "sentiment": "none"}], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "waltham", "sentiment": "none"}], "organizations": [{"name": "perkinelmer", "sentiment": "negative"}, {"name": "nyse", "sentiment": "negative"}, {"name": "pki", "sentiment": "negative"}, {"name": "perkinelmer, inc.", "sentiment": "neutral"}, {"name": "general electric company", "sentiment": "none"}, {"name": "ge", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Company as an advisor for an interim period of time to ensure a smooth transition and integration for Mr. Mock.\n“I am excited to welcome Jamey to PerkinElmer and look forward to his contributions, as he brings extensive experience overseeing the financial and commercial management of leading global organizations,” said Robert F. Friel, PerkinElmer’s president and chief executive officer. “Jamey’s financial leadership capabilities are an ideal complement to our focus on driving PerkinElmer to its next phase of growth and profitability.”\nMr. Mock joins PerkinElmer after serving for nearly 20 years in a wide range of financial oversight capacities within General Electric Company (GE). He was most recently vice president, Corporate Audit Staff, where he worked globally across GE’s businesses on controllership reviews and operational excellence projects. Prior to that, he served in a number of progressively responsible leadership roles in multifaceted global businesses based in the United States and overseas.\nAbout PerkinElmer\nPerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com .\nFactors Affecting Future Performance\nThis press release contains \"forward-looking\" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as \"believes,\" \"intends,\" \"anticipates,\" \"plans,\" \"expects,\" \"projects,\" \"forecasts,\" \"will\" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses such as EUROIMMUN and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) the United Kingdom’s intention to withdraw from the European Union; (21) our ability to realize the full value of our intangible assets; (22) significant fluctuations in our stock price; (23) reduction or elimination of dividends on our common stock; and (24) other factors which we describe under the caption \"Risk Factors\" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.\n //www.businesswire.com/news/home/20180410005430/en/\nPerkinElmer, Inc.\nInvestor Relations:\nTommy J. Thomas, 781-663-5889\ntommy.thomas@perkinelmer.com\nor\nMedia:\nBrian Willinsky, 781-663-5728\nbrian.willinsky@perkinelmer.com\nSource: PerkinElmer, Inc.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.perkinelmer.com%2F&esheet=51785839&newsitemid=20180410005430&lan=en-US&anchor=PerkinElmer%2C+Inc.&index=1&md5=0d0ac0e01f5ee5f3aba253f493eb21a4", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.perkinelmer.com&esheet=51785839&newsitemid=20180410005430&lan=en-US&anchor=www.perkinelmer.com&index=2&md5=fa1640d69cbff195a92b6e2ee43daf55", "https://www.businesswire.com/news/home/20180410005430/en/"], "published": "2018-04-11T00:30:00.000+03:00", "crawled": "2018-04-11T00:37:07.004+03:00", "highlightTitle": ""}